A pilot study: a combined therapy using polymyxin-B hemoperfusion and extracorporeal membrane oxygenation for acute...

Area of Science:

• Pulmonary Medicine
• Critical Care
• Nephrology

Background:

• Acute exacerbation of interstitial pneumonia (AE of IP) presents a significant clinical challenge.
• Polymyxin B-immobilized fiber direct hemoperfusion (PMX-DHP) is a potential treatment for inflammatory conditions.
• Venovenous extracorporeal membrane oxygenation (VV-ECMO) is an emerging therapy to support severe respiratory failure and prevent ventilator-induced lung injury.

Observation:

• This report details the first three patients with AE of IP treated with a combination of PMX-DHP and VV-ECMO.
• Patients presented with severe hypoxemia requiring mechanical ventilation.
• The combined therapy was administered alongside corticosteroids and antibiotics.

Findings:

• All three patients demonstrated marked improvement in radiological findings, oxygenation parameters, and laboratory markers.
• Successful outcomes were achieved with no severe complications reported.
• This suggests a potential benefit of the combined therapeutic approach.

Implications:

• The combination of PMX-DHP and VV-ECMO may represent a viable therapeutic option for managing AE of IP.
• Further research is warranted to validate these findings in larger patient cohorts.
• This approach could offer new hope for patients with severe, refractory AE of IP.